Logo image of OLK

OLINK HOLDING AB - ADR (OLK) Stock Fundamental Analysis

NASDAQ:OLK - Nasdaq - US6807101000 - ADR - Currency: USD

26.08  +0.08 (+0.31%)

After market: 26.02 -0.06 (-0.23%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to OLK. OLK was compared to 54 industry peers in the Life Sciences Tools & Services industry. The financial health of OLK is average, but there are quite some concerns on its profitability. OLK is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

OLK had negative earnings in the past year.
OLK had a negative operating cash flow in the past year.
OLK had negative earnings in each of the past 5 years.
OLK had a negative operating cash flow in each of the past 5 years.
OLK Yearly Net Income VS EBIT VS OCF VS FCFOLK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -20M -40M -60M

1.2 Ratios

OLK's Return On Assets of -6.21% is in line compared to the rest of the industry. OLK outperforms 57.89% of its industry peers.
With a decent Return On Equity value of -7.30%, OLK is doing good in the industry, outperforming 64.91% of the companies in the same industry.
Industry RankSector Rank
ROA -6.21%
ROE -7.3%
ROIC N/A
ROA(3y)-5.28%
ROA(5y)-5.94%
ROE(3y)-6.12%
ROE(5y)-8.05%
ROIC(3y)N/A
ROIC(5y)N/A
OLK Yearly ROA, ROE, ROICOLK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -2 -4 -6 -8 -10

1.3 Margins

OLK's Gross Margin of 66.88% is amongst the best of the industry. OLK outperforms 96.49% of its industry peers.
OLK's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for OLK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.08%
GM growth 5YN/A
OLK Yearly Profit, Operating, Gross MarginsOLK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40 -40 60 -60

More info and screens

5

2. Health

2.1 Basic Checks

OLK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OLK has more shares outstanding
The debt/assets ratio for OLK is higher compared to a year ago.
OLK Yearly Shares OutstandingOLK Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
OLK Yearly Total Debt VS Total AssetsOLK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

OLK has an Altman-Z score of 23.79. This indicates that OLK is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of OLK (23.79) is better than 100.00% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that OLK is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.05, OLK is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 23.79
ROIC/WACCN/A
WACC8.56%
OLK Yearly LT Debt VS Equity VS FCFOLK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 5.60 indicates that OLK has no problem at all paying its short term obligations.
With a decent Current ratio value of 5.60, OLK is doing good in the industry, outperforming 73.68% of the companies in the same industry.
OLK has a Quick Ratio of 3.91. This indicates that OLK is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of OLK (3.91) is better than 64.91% of its industry peers.
Industry RankSector Rank
Current Ratio 5.6
Quick Ratio 3.91
OLK Yearly Current Assets VS Current LiabilitesOLK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

6

3. Growth

3.1 Past

OLK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -145.45%.
OLK shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.16%.
Measured over the past years, OLK shows a very strong growth in Revenue. The Revenue has been growing by 46.35% on average per year.
EPS 1Y (TTM)-145.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.18%
Revenue 1Y (TTM)18.16%
Revenue growth 3Y46.35%
Revenue growth 5YN/A
Sales Q2Q%4.71%

3.2 Future

OLK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.84% yearly.
The Revenue is expected to grow by 17.43% on average over the next years. This is quite good.
EPS Next Y39.4%
EPS Next 2Y48.39%
EPS Next 3Y26.83%
EPS Next 5Y27.84%
Revenue Next Year13.93%
Revenue Next 2Y18.86%
Revenue Next 3Y16.25%
Revenue Next 5Y17.43%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
OLK Yearly Revenue VS EstimatesOLK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 100M 200M 300M 400M 500M
OLK Yearly EPS VS EstimatesOLK Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 0.4 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

OLK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 516.44 indicates a quite expensive valuation of OLK.
OLK's Price/Forward Earnings is on the same level as the industry average.
OLK's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 34.94.
Industry RankSector Rank
PE N/A
Fwd PE 516.44
OLK Price Earnings VS Forward Price EarningsOLK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OLK Per share dataOLK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates OLK does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as OLK's earnings are expected to grow with 26.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.39%
EPS Next 3Y26.83%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OLK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OLINK HOLDING AB - ADR

NASDAQ:OLK (7/9/2024, 9:30:55 PM)

After market: 26.02 -0.06 (-0.23%)

26.08

+0.08 (+0.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)05-13 2024-05-13/bmo
Earnings (Next)08-07 2024-08-07/amc
Inst Owners0.72%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.24B
Analysts49.09
Price Target26.52 (1.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-62.11%
Min EPS beat(2)-140.27%
Max EPS beat(2)16.06%
EPS beat(4)3
Avg EPS beat(4)-0.81%
Min EPS beat(4)-140.27%
Max EPS beat(4)87.62%
EPS beat(8)7
Avg EPS beat(8)85.65%
EPS beat(12)9
Avg EPS beat(12)29.05%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.13%
Min Revenue beat(2)-24.47%
Max Revenue beat(2)-5.8%
Revenue beat(4)1
Avg Revenue beat(4)-10.43%
Min Revenue beat(4)-24.47%
Max Revenue beat(4)1.11%
Revenue beat(8)4
Avg Revenue beat(8)-4%
Revenue beat(12)7
Avg Revenue beat(12)-1.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-1.96%
EPS NQ rev (3m)-8.33%
EPS NY rev (1m)0%
EPS NY rev (3m)23.08%
Revenue NQ rev (1m)-0.9%
Revenue NQ rev (3m)0.59%
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.6%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 516.44
P/S 18.98
P/FCF N/A
P/OCF N/A
P/B 7.02
P/tB 14.73
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)0.05
Fwd EY0.19%
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS1.37
BVpS3.71
TBVpS1.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.21%
ROE -7.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.88%
FCFM N/A
ROA(3y)-5.28%
ROA(5y)-5.94%
ROE(3y)-6.12%
ROE(5y)-8.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.08%
GM growth 5YN/A
F-Score1
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 99.62%
Cap/Sales 11.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.6
Quick Ratio 3.91
Altman-Z 23.79
F-Score1
WACC8.56%
ROIC/WACCN/A
Cap/Depr(3y)84.99%
Cap/Depr(5y)70.46%
Cap/Sales(3y)11.41%
Cap/Sales(5y)11.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-145.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.18%
EPS Next Y39.4%
EPS Next 2Y48.39%
EPS Next 3Y26.83%
EPS Next 5Y27.84%
Revenue 1Y (TTM)18.16%
Revenue growth 3Y46.35%
Revenue growth 5YN/A
Sales Q2Q%4.71%
Revenue Next Year13.93%
Revenue Next 2Y18.86%
Revenue Next 3Y16.25%
Revenue Next 5Y17.43%
EBIT growth 1Y-82.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year91.53%
EBIT Next 3Y58.32%
EBIT Next 5Y46.35%
FCF growth 1Y4.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.22%
OCF growth 3YN/A
OCF growth 5YN/A